UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma

PloS one, 2012-09, Vol.7 (9), p.e46005-e46005

2012

Volltextzugriff (PDF)

Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations

Hematology, Transfusion and Cell Therapy, 2020-07, Vol.42 (3), p.269-274

2020

Volltextzugriff (PDF)

Methylation status of nine tumor suppressor genes in multiple myeloma

International journal of hematology, 2010-01, Vol.91 (1), p.87-96

2010

Volltextzugriff (PDF)

TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes

Blood advances, 2022-01, Vol.6 (1), p.100-107

2022

Volltextzugriff (PDF)

Characterization of a human induced Pluripotent Stem (iPS) cell line (INCABRi002-A) derived from a primary myelofibrosis patient harboring the 5-bp insertion in CALR and the p.W146X mutation in TP53

Stem cell research, 2018-12, Vol.33, p.130-134

2018

Volltextzugriff (PDF)

miRNome profiling of LSC-enriched CD34 + CD38 - CD26 + fraction in Ph + CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool

Frontiers in pharmacology, 2021-01, Vol.11, p.612573-612573

2021

Volltextzugriff (PDF)

Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods

Hematology, Transfusion and Cell Therapy, 2020-07, Vol.42 (3), p.261-268

2020

Volltextzugriff (PDF)

miRNA-451: A putative predictor marker of Imatinib therapy response in chronic myeloid leukemia

Leukemia research, 2012-01, Vol.36 (1), p.119-121

2012

Volltextzugriff (PDF)

Molecular Genetics of Glioblastomas

Neuroimaging clinics of North America, 2015-02, Vol.25 (1), p.97-103

2015

Volltextzugriff (PDF)

Improved diagnosis of the transition to JAK2 (V⁶¹⁷F) homozygosity: the key feature for predicting the evolution of myeloproliferative neoplasms

PloS one, 2014, Vol.9 (1), p.e86401-e86401

2014

Volltextzugriff (PDF)

TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood

Leukemia research, 2015-10, Vol.39 (10), p.1103-1108

2015

Volltextzugriff (PDF)

Myeloid malignancies‐related somatic mutations in aging individuals

Molecular genetics & genomic medicine, 2019-06, Vol.7 (6), p.e683-n/a

2019

Volltextzugriff (PDF)

JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis

Digestive diseases and sciences, 2010-06, Vol.55 (6), p.1770-1777

2010

Volltextzugriff (PDF)

Understanding Genetics in Neuroimaging

Neuroimaging clinics of North America, 2015-02, Vol.25 (1), p.1-16

2015

Volltextzugriff (PDF)

Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52bp deletion and the ASXL1 p.R693X mutation

Stem cell research, 2017-10, Vol.24, p.16-20

2017

Volltextzugriff (PDF)

Epstein-Barr virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma

Diagnostic pathology, 2006-08, Vol.1 (1), p.17-17

2006

Volltextzugriff (PDF)

Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region

Haematologica (Roma), 2008-05, Vol.93 (5), p.780-783

2008

Volltextzugriff (PDF)

Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52 bp deletion and the ASXL1 p.R693X mutation

Stem cell research, 2017-10, Vol.24 (C), p.16-20

2017

Volltextzugriff (PDF)

Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature

Frontiers in oncology, 2018-02, Vol.8, p.32-32

2018

Volltextzugriff (PDF)

Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients

Leukemia & lymphoma, 2010-08, Vol.51 (8), p.1513-1526

2010

Volltextzugriff (PDF)

Familial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline Predisposition

Frontiers in oncology, 2017-09, Vol.7, p.206

2017

Volltextzugriff (PDF)

Somatic genomic variants in refractory cytopenia of childhood

Pediatric hematology oncology journal, 2021-09, Vol.6 (3), p.123-126

2021

Volltextzugriff (PDF)

Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports

Journal of medical case reports, 2017-05, Vol.11 (1), p.143-143, Article 143

2017

Volltextzugriff (PDF)

Early molecular response ≤1% has strong prognostic impact for CML patients that switch to second‐line therapy with BCR‐ABL1 ≤10% and no major molecular response

British journal of haematology, 2019-05, Vol.185 (4), p.770-772

2019

Volltextzugriff (PDF)

Abstract 5486: Time-dependent mathematical modeling of genetic alterations in acute myeloid leukemia

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5486-5486

2020

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(117)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(69)
Humans
(58)
Hematology
(48)
Oncology
(37)
Male
(31)
Female
(28)
Mutation
(19)
Middle Aged
(17)
Adult
(16)
Prognosis
(16)
Aged
(15)
Adolescent
(14)
Child
(12)
Polymerase Chain Reaction
(12)
Biological And Medical Sciences
(11)
Child, Preschool
(11)
Leukemia
(11)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(11)
Medicine, Research & Experimental
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Relationship of Epstein-Barr virus and interleukin 10 promoter polymorphisms with the risk and clinical outcome of childhood Burkitt lymphoma

Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations

Methylation status of nine tumor suppressor genes in multiple myeloma

TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes

Characterization of a human induced Pluripotent Stem (iPS) cell line (INCABRi002-A) derived from a primary myelofibrosis patient harboring the 5-bp insertion in CALR and the p.W146X mutation in TP53

miRNome profiling of LSC-enriched CD34 + CD38 - CD26 + fraction in Ph + CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool

Detection of somatic TP53 mutations and 17p deletions in patients with chronic lymphocytic leukemia: a review of the current methods

miRNA-451: A putative predictor marker of Imatinib therapy response in chronic myeloid leukemia

Molecular Genetics of Glioblastomas

Improved diagnosis of the transition to JAK2 (V⁶¹⁷F) homozygosity: the key feature for predicting the evolution of myeloproliferative neoplasms

TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood

Myeloid malignancies‐related somatic mutations in aging individuals

JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis

Understanding Genetics in Neuroimaging

Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52bp deletion and the ASXL1 p.R693X mutation

Epstein-Barr virus (EBV) detection and typing by PCR: a contribution to diagnostic screening of EBV-positive Burkitt's lymphoma

Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region

Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52 bp deletion and the ASXL1 p.R693X mutation

Genetic Alterations in Essential Thrombocythemia Progression to Acute Myeloid Leukemia: A Case Series and Review of the Literature

Cell cycle characteristics and Epstein-Barr virus are differentially associated with aggressive and non-aggressive subsets of Hodgkin lymphoma in pediatric patients

Familial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline Predisposition

Somatic genomic variants in refractory cytopenia of childhood

Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports

Early molecular response ≤1% has strong prognostic impact for CML patients that switch to second‐line therapy with BCR‐ABL1 ≤10% and no major molecular response

Abstract 5486: Time-dependent mathematical modeling of genetic alterations in acute myeloid leukemia

Suchergebnisse filtern